FDA grants full approval to AbbVie’s ovarian cancer drug ELAHERE

AbbVie (NYSE: ABBV) has achieved a significant milestone in the fight against ovarian cancer with the U.S. Food and Drug Administration (FDA) granting full approval ... Read More